Showing results (21-30 of 4,868) with videos related to
Sort By:
Pageof 487
Urologic Oncology|May 22, 2012
Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell linesOlivier Guérin, Marie-Christine Etienne-Grimaldi, Martino Monteverde, et al.Urologic Oncology|May 22, 2012
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospitalRajal B Shah, Jeffrey S Montgomery, James E Montie, et al.Urologic Oncology|December 4, 2014
Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinomaThai H Ho, Payal Kapur, Richard W Joseph, et al.Urologic Oncology|December 4, 2014
Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?Armin Soave, Selina Schmidt, Roland Dahlem, et al.Urologic Oncology|January 3, 2015
Pulmonary and cardiovascular toxicity in long-term testicular cancer survivorsHege S Haugnes, Jan Oldenburg, Roy M BremnesUrologic Oncology|December 31, 2014
The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancerAndrew C Harbin, Daniel D EunUrologic Oncology|January 6, 2015
Irreversible electroporation of the porcine kidney: Temperature development and distributionPeter G K Wagstaff, Daniel M de Bruin, Willemien van den Bos, et al.Urologic Oncology|July 6, 2014
The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal-Implications for targeted therapiesMeike Schneider, Nina Korzeniewski, Konstanze Merkle, et al.Urologic Oncology|July 6, 2014
Genetic predisposition to prostate cancer: Update and future perspectivesFrancesca Demichelis, Janet L StanfordUrologic Oncology|July 6, 2014
A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosisGuorong Li, Fabien Forest, Gang Feng, et al.Pageof 487